PharmTech Drug Digest 11.20
News|Articles|May 17, 2016

Jones Packaging and TUKU Develop Web-Enabled Packaging Platform

The companies entered into a commercial collaboration to develop web-enabled packaging for pharmaceutical and consumer goods companies.

On May 17, 2016, Jones Packaging entered into a commercial collaboration with TUKU, a mobile marketing company, according to a press announcement. The companies will integrate TUKU’s content management technology with Jones’ printed packaging solutions to provide web-enabled packaging to pharmaceutical and consumer packaged goods companies. The integrated platform will deliver product information and promotions direct from the package to consumers’ mobile devices.

The combination of Jones’ connected packaging with TUKU’s content delivery platform creates a new, in-store media channel that communicates brand messages to consumer mobile devices at the point of retail display, Jones said in a press announcement. The technology engages with the consumer who taps their near field communication-enabled device to the package, or scans a QR code, to activate media messages. The message can be customized and adapted in real-time to deliver promotions at the store and SKU level for a specified date–time range. In addition, the channel facilitates social sharing, social commerce, peer recommendation, peer validation, and a range of custom options.

Source: Jones Packaging


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.